Merck & Co., Inc.
MRK
$104.83
$0.200.19%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.30% | 1.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.30% | 1.78% | |||
| Cost of Revenue | 10.41% | 0.27% | |||
| Gross Profit | 9.00% | 2.21% | |||
| SG&A Expenses | -0.60% | 3.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.48% | 6.18% | |||
| Operating Income | 19.01% | -4.79% | |||
| Income Before Tax | 34.93% | -15.31% | |||
| Income Tax Expenses | 67.78% | -30.20% | |||
| Earnings from Continuing Operations | 30.69% | -12.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -100.00% | 83.33% | |||
| Net Income | 30.68% | -12.84% | |||
| EBIT | 19.01% | -4.79% | |||
| EBITDA | 16.60% | -4.01% | |||
| EPS Basic | 31.46% | -12.39% | |||
| Normalized Basic EPS | 19.79% | -5.04% | |||
| EPS Diluted | 31.74% | -12.44% | |||
| Normalized Diluted EPS | 19.78% | -4.85% | |||
| Average Basic Shares Outstanding | -0.60% | -0.52% | |||
| Average Diluted Shares Outstanding | -0.60% | -0.71% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.25% | 0.16% | |||